⟵ Back to Search Results

BGB-A317-304

Active, not recruiting

A Study Evaluating the Efficacy and Safety of Tislelizumab Versus Chemotherapy in Advanced Non-Squamous NSCLC

Beigene Study ID info

BGB-A317-304

ClinicalTrials.gov ID info

NCT03663205

China Drug Trials ID info

CTR20180032

Study Overview

Sex: All

Age: 18 Years to 75 Years   (Adult, Older Adult)

No Study Documents

Study Overview

Sex: All

Age: 18 Years to 75 Years   (Adult, Older Adult)

No Study Documents